Gene editing shows promise in curing herpes infections

Researchers at Fred Hutch Cancer Center have developed an experimental gene therapy for herpes, removing 90% or more of the infection in pre-clinical studies. The therapy reduces viral shedding, potentially limiting transmission. The simplified treatment is safer and more effective, targeting both oral and genital herpes. The therapy aims to cure the infection, benefiting the estimated 3.7 billion with HSV-1 and 491 million with HSV-2 worldwide.